These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 32365863)

  • 41. Coronary microvascular disease: The "Meeting Point" of Cardiology, Rheumatology and Endocrinology.
    Markousis-Mavrogenis G; Bacopoulou F; Mavragani C; Voulgari P; Kolovou G; Kitas GD; Chrousos GP; Mavrogeni SI
    Eur J Clin Invest; 2022 May; 52(5):e13737. PubMed ID: 34939183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure.
    Perrino C; Schiattarella GG; Sannino A; Pironti G; Petretta MP; Cannavo A; Gargiulo G; Ilardi F; Magliulo F; Franzone A; Carotenuto G; Serino F; Altobelli GG; Cimini V; Cuocolo A; Lombardi A; Goglia F; Indolfi C; Trimarco B; Esposito G
    J Am Heart Assoc; 2013 May; 2(3):e000086. PubMed ID: 23688674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrated physiologic assessment of ischemic heart disease in real-world practice using index of microcirculatory resistance and fractional flow reserve: insights from the International Index of Microcirculatory Resistance Registry.
    Lee JM; Layland J; Jung JH; Lee HJ; Echavarria-Pinto M; Watkins S; Yong AS; Doh JH; Nam CW; Shin ES; Koo BK; Ng MK; Escaned J; Fearon WF; Oldroyd KG
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e002857. PubMed ID: 26499500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
    Jones E; Wei J; Nelson MD; Bakir M; Mehta PK; Shufelt C; Minissian M; Sharif B; Pepine CJ; Handberg E; Cook-Wiens G; Sopko G; Bairey Merz CN
    PLoS One; 2020; 15(12):e0243213. PubMed ID: 33270715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perturbations in myocardial perfusion and oxygen balance in swine with multiple risk factors: a novel model of ischemia and no obstructive coronary artery disease.
    van de Wouw J; Sorop O; van Drie RWA; van Duin RWB; Nguyen ITN; Joles JA; Verhaar MC; Merkus D; Duncker DJ
    Basic Res Cardiol; 2020 Feb; 115(2):21. PubMed ID: 32100119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coronary vascular K+ATP channels contribute to the maintenance of myocardial perfusion in dogs with pacing-induced heart failure.
    Yamamoto M; Egashira K; Arimura K; Tada H; Shimokawa H; Takeshita A
    Jpn Circ J; 2000 Sep; 64(9):701-7. PubMed ID: 10981856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.
    Jaffe R; Dick A; Strauss BH
    JACC Cardiovasc Interv; 2010 Jul; 3(7):695-704. PubMed ID: 20650430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: is ischemic heart disease primarily adrenergic cardiovascular disease?
    Bacaner M; Brietenbucher J; LaBree J
    Am J Ther; 2004; 11(5):366-411. PubMed ID: 15356432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on Coronary Pathophysiology and Microcirculation position paper.
    Koller A; Laughlin MH; Cenko E; de Wit C; Tóth K; Bugiardini R; Trifunovits D; Vavlukis M; Manfrini O; Lelbach A; Dornyei G; Padro T; Badimon L; Tousoulis D; Gielen S; Duncker DJ
    Cardiovasc Res; 2022 Jan; 118(2):357-371. PubMed ID: 34358290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular Death.
    Hong D; Lee SH; Shin D; Choi KH; Kim HK; Ha SJ; Joh HS; Park TK; Yang JH; Song YB; Hahn JY; Choi SH; Gwon HC; Lee JM
    J Am Heart Assoc; 2023 Feb; 12(3):e027690. PubMed ID: 36695307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction.
    Del Buono MG; Moroni F; Montone RA; Azzalini L; Sanna T; Abbate A
    Curr Cardiol Rep; 2022 Oct; 24(10):1505-1515. PubMed ID: 35972638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systolic ventricular dysfunction and heart failure due to coronary microangiopathy in hypertensive heart disease.
    Vogt M; Strauer BE
    Am J Cardiol; 1995 Nov; 76(13):48D-53D. PubMed ID: 7495218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure.
    Dai Z; Aoki T; Fukumoto Y; Shimokawa H
    J Cardiol; 2012 Nov; 60(5):416-21. PubMed ID: 22867802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. How to study coronary microvascular dysfunction and its clinical relevance.
    L'Abbate A; Sambuceti G
    Ital Heart J; 2002 Apr; 3(4):230-6. PubMed ID: 12025371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of beneficial effects of vasodilators and inotropic stimulation in the experimental failing ischemic heart.
    Kirk ES; LeJemtel TH; Nelson GR; Sonnenblick EH
    Am J Med; 1978 Jul; 65(1):189-96. PubMed ID: 685993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of cardiac failure by coronary small vessel disease in hypertensive heart disease?
    Strauer BE
    J Hypertens Suppl; 1991 Dec; 9(2):S11-20; discussion S20-1. PubMed ID: 1838764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The many faces of myocardial ischaemia and angina.
    Levy BI; Heusch G; Camici PG
    Cardiovasc Res; 2019 Aug; 115(10):1460-1470. PubMed ID: 31228187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microvascular angina (Cardiac Syndrome X) from a historical overview, epidemiology, pathophysiology to treatment recommendations - a minireview.
    Jarczewski J; Jarczewska A; Boryczko A; Poniatowski A; Furgała A; Surdacki A; Gil K
    Folia Med Cracov; 2021 Sep; 61(3):95-114. PubMed ID: 34882667
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy.
    Dean J; Cruz SD; Mehta PK; Merz CN
    Nat Rev Cardiol; 2015 Jul; 12(7):406-14. PubMed ID: 26011377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coronary microvascular dysfunction in stable ischaemic heart disease (non-obstructive coronary artery disease and obstructive coronary artery disease).
    Sechtem U; Brown D; Godo S; Lanza GA; Shimokawa H; Sidik N
    Cardiovasc Res; 2020 Mar; 116(4):771-786. PubMed ID: 31958128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.